NEWS

TRICOPHARMING AND SEQUENTIA JOIN FOR INTEGRATED SOLUTIONS

 150 150 marketing
By:

We joined with Sequentia Biotech, to integrate our workflows and provide an end to end solution for research and development of biostimulants. We take care from field testing to bioinformatics analysis, to test and analyze the effectiveness of an already existing biostimulant, or an in-house tailored made to fit your needs.

read more

LEARN MORE ABOUT ARTEMISIA ANNUA AND OUR OPTIMIZED VERSION, ARTENNUA®

 150 150 marketing
By:

Artemisia annua is an aromatic herbaceous plant native to Asia, a species that stands out from the rest of its genus as an excellent and important source of clinically proven therapeutic compounds. Artemisia annua L. produces a range of complex terpenoids in its trichomes, among which artemisinin is of particular interest for the treatment of…

read more

WE ARE NOW PART OF ICEX NEXT

 150 150 marketing
By:

Tricopharming is from now on and for the next 24 months, part of the ICEX-Next Export Initiation Program, with the support of ICEX and the co-financing of European FEDER fund. The purpose of this program is to contribute to design the strategy and to identify the necessary steps to develop the international expansion of the…

read more

CANNABIS: ITS MOLECULES AND USES

 150 150 marketing
By:

Cannabis (or hemp) is a flowering plant from the family Cannabaceae, a subset of the order of Urticales. There are three species: Sativa, Indica and Ruderalis and several subspecies. Physically, even with considerable variations, it has an average height of 1.5 – 2 meters and is characterized by palmed leaves and straight, hairy stems.  The…

read more